BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Deloitte
Federal Trade Commission
UBS
Healthtrust
Moodys
Express Scripts
Harvard Business School
Cantor Fitzgerald
Accenture

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078338

« Back to Dashboard

NDA 078338 describes CLOTRIMAZOLE, which is a drug marketed by Fougera Pharms, Glenmark Pharms, Taro, Actavis Mid Atlantic, Teva, Paddock Llc, and West-ward Pharms Int, and is included in fifteen NDAs. It is available from nineteen suppliers. Additional details are available on the CLOTRIMAZOLE profile page.

The generic ingredient in CLOTRIMAZOLE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.
Summary for 078338
Tradename:CLOTRIMAZOLE
Applicant:Fougera Pharms
Ingredient:clotrimazole
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Pharmacology for NDA: 078338
Ingredient-typeAzoles
Medical Subject Heading (MeSH) Categories for 078338
Suppliers and Packaging for NDA: 078338
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOTRIMAZOLE clotrimazole CREAM;TOPICAL 078338 ANDA E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. 0168-0133 0168-0133-15 15 g in 1 TUBE (0168-0133-15)
CLOTRIMAZOLE clotrimazole CREAM;TOPICAL 078338 ANDA E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. 0168-0133 0168-0133-46 45 g in 1 TUBE (0168-0133-46)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Sep 2, 2008TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Daiichi Sankyo
Cipla
Cerilliant
Fish and Richardson
Merck
Mallinckrodt
Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot